secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-07-05T23:59:59+00:00
Accession:  0001493152-24-026374
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics announces 1-for-10 reverse stock split effective July 15, 2024
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio effective 12:01 a.m. ET on July 15, 2024.
- Common stock to trade on split-adjusted basis under symbol CLDI starting July 15.
- No fractional shares issued; fractional shares rounded up to nearest whole share.
- Warrants adjusted: public warrants exercisable for 1/10th share at $115/whole share; private warrants exercise price x10.
- New CUSIP for common stock: 320703 309; warrants CUSIP unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224026374/0001493152-24-026374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224026374/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-026374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer